Potency degrades over time, and you cannot assess peptide integrity by appearance
Furthermore, the option to continue or initiate new AD medication during the trial, including the amyloid lowering monoclonal antibodies, was not a randomization stratification factor and may therefore act as a confounding factor if their use across treatment arms is unequal
Destefanis F, Manara V, Bellosta P
Promoting satiety and fullness
Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS)/Drug-Induced Hypersensitivity Syndrome (DiHS)-Readdressing the DReSS
The kinetics of the contents of the blood compartment are complicated because GSH and its component amino acids in the blood interact with the kidney, the brain, and other tissues